1 Consumer Stock with Exciting Potential and 2 We Avoid
Featuring original designs from acclaimed artists, the nationwide initiative celebrates America's 250th anniversary through collectible metal ZYN cases
Philip Morris International ($PM) said the U.S. Food and Drug Administration has authorized 20 variants of its Zyn nicotine pouches to be marketed as posing a lower health risk than cigarettes. The authorization...
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes
Nearly 8 in 10 Americans surveyed say the country is innovating in the wrong areas, while 86% say the most meaningful innovations are not the headline makers but those that solve problems ordinary people...
Philip Morris is expected to announce its second-quarter earnings in July, and Wall Street expects the company’s EPS to increase by a single-digit percentage.
A new platform for dialogue on progress, reflecting a mutual commitment to advancing positive change
The ranking recognizes companies best positioned to thrive amid AI-driven and structural economic change
Philip Morris (PM) Stock Is Up, What You Need To Know
Philip Morris International and WSJ Intelligence reveal a "Human Premium" in the AI era, warning of cognitive atrophy risks alongside rapid corporate automation